# Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of ACD856

> **NCT05077501** · PHASE1 · COMPLETED · sponsor: **AlzeCure Pharma** · enrollment: 24 (actual)

## Conditions studied

- Alzheimer Disease
- Cognition Disorder

## Interventions

- **DRUG:** ACD856
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05077501
- **Lead sponsor:** AlzeCure Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-29
- **Primary completion:** 2022-05-16
- **Final completion:** 2022-05-23
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05077501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05077501, "Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of ACD856". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05077501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*